Advertisement
Logo
Search for

Volume 139, Issue 5, Pages 900-905 (May 2005)


View previous. 19 of 68 View next.

Improving the Reporting of Clinical Case Series

Douglas A. Jabs, MD, MBAabCorresponding Author Informationemail address

Accepted 3 December 2004. published online 21 March 2005.

Purpose

To describe common errors in the analyses and data presentation of a clinical case series and to suggest simple solutions.

Design

Instructional examples.

Methods

Problems with commonly used data analysis and reporting techniques in clinical case series are described using both theoretical examples and those from the literature.

Results

An analysis reporting the proportion of a series of patients with variable follow-up does not adequately account for the differential follow-up among patients and is a potentially misleading way to present data. Instead, the proportion of patients at presentation (or study entry) and the rate during follow-up should be reported. Similarly, an analysis in which the final visual acuity of a series of patients with variable follow-up is reported does not adequately account for the effect of time and also may be misleading. Reporting of the rates of visual acuity events during follow-up (e.g., falling below a specified threshold, such as 20/50 or worse) is preferred. Alternatively, when there is nearly complete follow-up, reporting the distribution of visual acuity at specified time points (e.g., 1 year after study presentation) is appropriate. Small case series should not be overinterpreted because of the effects of chance, and appropriate statistical analyses should be employed.

Conclusions

Clinical case series often suffer from several potential reporting flaws. Correction of these flaws would permit the proper interpretation of the data and allow for the ability to combine data from several case series to assemble more meaningful and reliable conclusions.

a Departments of Ophthalmology and Medicine, The Johns Hopkins University School of Medicine

b Department of Epidemiology, The Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland

Corresponding Author InformationInquiries to Douglas Jabs, MD, The Wilmer Eye Institute, 550 North Broadway, Suite #700, Baltimore, MD 21205; Fax: (410) 955-0629

 Supported in part by grant EY 00405 from the National Eye Institute, National Institutes of Health, Bethesda, MD.

 The Editors-in-Chief of the American Journal of Ophthalmology, Archives of Ophthalmology, and Ophthalmology have reviewed the manuscript, and with the approval of the author, have included this manuscript in the Editorship series of these three journals.

PII: S0002-9394(04)01490-4

doi:10.1016/j.ajo.2004.12.009


View previous. 19 of 68 View next.

Advertisement